OXIGENE, INC. JUNE 30, 2002 10Q

Company

Oncotelic Therapeutics, Inc.

Filed

August 14, 2002

Period of Report

June 30, 2002

Accession Number

0000908259-02-000008

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →